Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney (Renal Pelvis)

NCT00959153 is registered in ClinicalTrials.gov with Advance Shockwave Technology GmbH as lead sponsor.

NCT NCT00959153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00959153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney (Renal Pelvis)
Lead sponsor
Advance Shockwave Technology GmbH
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2010
Completion date
August 31, 2011
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

kidney stones